Pubblicazioni

Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma

2024 - BONE MARROW TRANSPLANTATION
De Philippis, Chiara; Zucchinetti, Cristina; Mannina, Daniele; Krampera, Mauro; Zinzani, Pier Luigi; Chiappella, Annalisa; di Rocco, Alice; Orcioulo, Enrico; Tisi, Maria Chiara; Pistolese, Flavio; Giordano, Laura; Santoro, Armando; Bramanti, Stefania

Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group

2024 - BONE MARROW TRANSPLANTATION
Fazio, F.; Passucci, M.; Micozzi, J.; Di Landro, F.; Fianchi, L.; Za, T.; Manieri, V. M.; Annibali, O.; Cupelli, L.; Bongarzoni, V.; Gentili, S.; De Padua, L.; Crisanti, E.; Garzia, M. G.; Rago, A.; Piciocchi, A.; Mengarelli, A.; Morè, S.; De Stefano, V.; Bafti, M. S.; Martelli, M.; Petrucci, M. T.

Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation

2024 - BONE MARROW TRANSPLANTATION
Singh, Rohan Bir; Cho, Wonkyung; Liu, Catherine; Naderi, Amirreza; Surico, Pier Luigi; Kahale, Francesca; Dohlman, Thomas H.; Chauhan, Sunil K.; Dana, Reza

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

2024 - BONE MARROW TRANSPLANTATION
Beelen, Dietrich Wilhelm; Iacobelli, Simona; Koster, Linda; Eikema, Dirk-Jan; van Biezen, Anja; Stölzel, Friedrich; Ciceri, Fabio; Bethge, Wolfgang; Dreger, Peter; Wagner-Drouet, Eva-Maria; Reményi, Péter; Stelljes, Matthias; Markiewicz, Miroslaw; Mclornan, Donal P.; Yakoub-Agha, Ibrahim; Mohty, Mohamad

Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic

2023 - BONE MARROW TRANSPLANTATION
Galli, E; Di Rocco, A; Pansini, I; Frondizi, F; Di Palma, M; Metafuni, E; Piccirillo, N; Bianchi, M; Cingolani, A; Torelli, Gf; Hohaus, S; Chiusolo, P; Iori, Ap; Sica, S; Martelli, M; Sora, F

An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT

2023 - BONE MARROW TRANSPLANTATION
Beksac, Meral; Iacobelli, Simona; Koster, Linda; Cornelissen, Jan; Griskevicius, Laimonas; Rabin, Neil K; Stoppa, Anne Marie; Meijer, Ellen; Mear, Jean-Baptiste; Zeerleder, Sacha; Mayer, Jiri; Fenk, Roland; Fegueux, Nathalie; Chevallier, Patrice; Konirova, Eva; Snowden, John A; Engelhardt, Monika; Orchard, Kim; Hulin, Cyrille; Schaap, Nicolaas; Sossa, Claudia; Elmaagacli, Ahmet; Mclornan, Donal P; Hayden, Patrick J; Schönland, Stefan; Yakoub-Agha, Ibrahim

Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

2022 - BONE MARROW TRANSPLANTATION
Czerw, T; Iacobelli, S; Malpassuti, V; Koster, L; Kroger, N; Robin, M; Maertens, J; Chevallier, P; Watz, E; Poire, X; Snowden, Ja; Kuball, J; Kinsella, F; Blaise, D; Remenyi, P; Mear, Jb; Cammenga, J; Rubio, Mt; Maury, S; Daguindau, E; Finnegan, D; Hayden, P; Hernandez-Boluda, Jc; Mclornan, D; Yakoub-Agha, I

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

2022 - BONE MARROW TRANSPLANTATION
Onida, F; Sbianchi, G; Radujkovic, A; Sockel, K; Kroger, N; Sierra, J; Socie, G; Cornelissen, J; Poire, X; Raida, L; Bourhis, Jh; Finke, J; Passweg, J; Salmenniemi, U; Schouten, Hc; Beguin, Y; Martin, S; Deconinck, E; Ganser, A; Zver, S; Lioure, B; Rohini, R; Koster, L; Hayden, P; Iacobelli, S; Robin, M; Yakoub-Agha, I

Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT

2022 - BONE MARROW TRANSPLANTATION
Masouridi-Levrat, S; Olavarria, E; Iacobelli, S; Aljurf, Md; Morozova, E; Niittyvuopio, R; Sengeloev, H; Remenyi, P; Helbig, G; Browne, P; Ganser, A; Nagler, A; Snowden, J; Robin, M; Passweg, J; Van Gorkom, G; Labussiere, H; Hoek, J; van Biezen, A; de Witte, T; Kroger, N; Hayden, P; Chalandon, Y; Yakoub-Agha, I

Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience

2021 - BONE MARROW TRANSPLANTATION
Bruzzese, Antonella; Assanto, Giovanni Manfredi; Diverio, Daniela; Quattrocchi, Luisa; Carmini, Daniela; La Rocca, Ursula; De Propris, Maria Stefania; Trisolini, Silvia Maria; Brescini, Mattia; Galassi, Giulia; Barberi, Walter; Iori, Anna Paola

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis

2021 - BONE MARROW TRANSPLANTATION
Lazzaro, Carlo; Castagna, Luca; Lanza, Francesco; Laszlo, Daniele; Milone, Giuseppe; Pierelli, Luca; Saccardi, Riccardo

Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w)

2021 - BONE MARROW TRANSPLANTATION
Bruzzese, A.; Assanto, G. M.; Diverio, D.; Quattrocchi, L.; Carmini, D.; La Rocca, U.; De Propris, M. S.; Trisolini, S. M.; Brescini, M.; Galassi, G.; Barberi, W.; Iori, A. P.

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14). A study from the CMWP-EBMT

2021 - BONE MARROW TRANSPLANTATION
Gagelmann, Nico; Eikema, Diderik-Jan; de Wreede, Liesbeth C; Rambaldi, Alessandro; Iacobelli, Simona; Koster, Linda; Caillot, Denis; Blaise, Didier; Remémyi, Péter; Bulabois, Claude-Eric; Passweg, Jakob; Leleu, Xavier; Zver, Samo; Kobbe, Guido; Ljungman, Per; Chevallier, Patrice; Ringhoffer, Mark; Martin, Murray; Salmenniemi, Urpu; Poiré, Xavier; Lenhoff, Stig; Pioltelli, Pietro; Mordini, Nicola; Delforge, Michel; Garderet, Laurent; Schönland, Stefan; Yakoub-Agha, Ibrahim; Kröger, Nicolaus

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation

2020 - BONE MARROW TRANSPLANTATION
Spreafico, F.; Dalissier, A.; Potschger, U.; Locatelli, F.; Michon, J. M.; Peters, C.; Bader, P.; Bisogno, G.; Yeomanson, D.; Willasch, A.; van den Heuvel Eibrink, M.; Graf, N.; Dallorso, S.

Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study

2020 - BONE MARROW TRANSPLANTATION
Willasch, A. M.; Peters, C.; Sedlacek, P.; Dalle, J. -H.; Kitra-Roussou, V.; Yesilipek, A.; Wachowiak, J.; Lankester, A.; Prete, A.; Hamidieh, A. A.; Ifversen, M.; Buechner, J.; Krivan, G.; Hamladji, R. -M.; Diaz-de-Heredia, C.; Skorobogatova, E.; Michel, G.; Locatelli, F.; Bertaina, A.; Veys, P.; Dupont, S.; Or, R.; Gungor, T.; Aleinikova, O.; Sufliarska, S.; Sundin, M.; Rascon, J.; Kaare, A.; Nemet, D.; Fagioli, F.; Klingebiel, T. E.; Styczynski, J.; Bierings, M.; Nagy, K.; Abecasis, M.; Afanasyev, B.; Ansari, M.; Vettenranta, K.; Alseraihy, A.; Chybicka, A.; Robinson, S.; Bertrand, Y.; Kupesiz, A.; Ghavamzadeh, A.; Campos, A.; Pichler, H.; Dalissier, A.; Labopin, M.; Corbacioglu, S.; Balduzzi, A.; Galimard, J. -E.; Bader, P.

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

2020 - BONE MARROW TRANSPLANTATION
Bacigalupo, A.; Angelucci, E.; Raiola, A. M.; Varaldo, R.; Di Grazia, C.; Gualandi, F.; Benedetti, E.; Risitano, A.; Musso, M.; Zallio, F.; Ciceri, F.; Chiusolo, P.; Sica, S.; Rambaldi, A.; Bonifazi, F.; Parma, M.; Martino, M.; Onida, F.; Iori, A. P.; Selleri, C.; Borghero, C.; Bertaina, A.; Prezioso, L.; Algeri, M.; Locatelli, F.

Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)

2020 - BONE MARROW TRANSPLANTATION
Morland, B.; Kepak, T.; Dallorso, S.; Sevilla, J.; Murphy, D.; Luksch, R.; Yaniv, I.; Bader, P.; Rossler, J.; Bisogno, G.; Maecker-Kolhoff, B.; Lang, P.; Zwaan, C. M.; Sumerauer, D.; Krivan, G.; Bernard, J.; Liu, Q.; Doyle, E.; Locatelli, F.

Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study

2020 - BONE MARROW TRANSPLANTATION
Saglio, F.; Zecca, M.; Pagliara, D.; Giorgiani, G.; Balduzzi, A.; Calore, E.; Favre, C.; Faraci, M.; Prete, A.; Tambaro, F. P.; Quarello, P.; Locatelli, F.; Fagioli, F.

Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) (Bone Marrow Transplantation, (2020), 55, 9, (1796-1809), 10.1038/s41409-020-0863-z)

2020 - BONE MARROW TRANSPLANTATION
Cesaro, S.; Pillon, M.; Sauer, M.; Smiers, F.; Faraci, M.; de Heredia, C. D.; Wynn, R.; Greil, J.; Locatelli, F.; Veys, P.; Uyttebroeck, A.; Ljungman, P.; Chevalier, P.; Ansari, M.; Badell, I.; Gungor, T.; Salim, R.; Tischer, J.; Tecchio, C.; Russell, N.; Chybicka, A.; Styczynski, J.; Krivan, G.; Smith, O.; Stein, J.; Afanasyev, B.; Pochon, C.; Menconi, M. C.; Bosman, P.; Mauro, M.; Tridello, G.; de Latour, R. P.; Dufour, C.

Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)

2020 - BONE MARROW TRANSPLANTATION
Morland, B.; Kepak, T.; Dallorso, S.; Sevilla, J.; Murphy, D.; Luksch, R.; Yaniv, I.; Bader, P.; Rossler, J.; Bisogno, G.; Maecker-Kolhoff, B.; Lang, P.; Zwaan, C. M.; Sumerauer, D.; Krivan, G.; Bernard, J.; Liu, Q.; Doyle, E.; Locatelli, F.

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

2020 - BONE MARROW TRANSPLANTATION
Ciurea, S. O.; Al Malki, M. M.; Kongtim, P.; Fuchs, E. J.; Luznik, L.; Huang, X. -J.; Ciceri, F.; Locatelli, F.; Aversa, F.; Castagna, L.; Bacigalupo, A.; Martelli, M.; Blaise, D.; Ben Soussan, P.; Arnault, Y.; Handgretinger, R.; Roy, D. -C.; O'Donnell, P. V.; Bashey, A.; Solomon, S.; Romee, R.; Gayoso, J.; Lazarus, H. M.; Ballen, K.; Savani, B. N.; Mohty, M.; Nagler, A.

Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

2020 - BONE MARROW TRANSPLANTATION
Cesaro, S.; Pillon, M.; Sauer, M.; Smiers, F.; Faraci, M.; de Heredia, C. D.; Wynn, R.; Greil, J.; Locatelli, F.; Veys, P.; Uyttebroeck, A.; Ljungman, P.; Chevalier, P.; Ansari, M.; Badell, I.; Gungor, T.; Salim, R.; Tischer, J.; Tecchio, C.; Russell, N.; Chybicka, A.; Styczynski, J.; Krivan, G.; Smith, O.; Stein, J.; Afanasyev, B.; Pochon, C.; Menconi, M. C.; Bosman, P.; Mauro, M.; Tridello, G.; de Latour, R. P.; Dufour, C.

Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies

2020 - BONE MARROW TRANSPLANTATION
Kalwak, K.; Mielcarek, M.; Patrick, K.; Styczynski, J.; Bader, P.; Corbacioglu, S.; Burkhardt, B.; Sykora, K. W.; Drabko, K.; Gozdzik, J.; Fagioli, F.; Greil, J.; Gruhn, B.; Beier, R.; Locatelli, F.; Muller, I.; Schlegel, P. G.; Sedlacek, P.; Stachel, K. D.; Hemmelmann, C.; Moller, A. -K.; Baumgart, J.; Vora, A.

TCRαβ/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum

2020 - BONE MARROW TRANSPLANTATION
Merli, P.; Vacca, P.; Galaverna, F.; Tumino, N.; Moretta, L.; Locatelli, F.

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

2020 - BONE MARROW TRANSPLANTATION
Bacigalupo, A.; Angelucci, E.; Raiola, A. M.; Varaldo, R.; Di Grazia, C.; Gualandi, F.; Benedetti, E.; Risitano, A.; Musso, M.; Zallio, F.; Ciceri, F.; Chiusolo, P.; Sica, S.; Rambaldi, A.; Bonifazi, F.; Parma, M.; Martino, M.; Onida, F.; Iori, A. P.; Selleri, C.; Borghero, C.; Bertaina, A.; Prezioso, L.; Algeri, M.; Locatelli, F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma